The White House said Medicaid programs in all 50 states, D.C. and Puerto Rico now receive MFN prices, with nearly $65 billion in savings over a decade.
News|Articles|September 21, 2026
FAQ: How the GENEROUS Model Applies MFN Pricing to Medicaid
Author(s)Stephen Appezzato
CMS says 40 states and Puerto Rico have signed on to the GENEROUS Model, which applies MFN pricing to Medicaid drugs through state-invoiced rebates.
Advertisement
Advertisement
The Centers for Medicare & Medicaid Services (CMS) announced Sept. 18 that all 50 states, the District of Columbia and Puerto Rico have applied to join the GENErating cost Reductions fOr US Medicaid (GENEROUS) Model, which provides most favored nation (MFN) pricing on certain prescription drugs to Medicaid programs.¹ Forty states and Puerto Rico have signed agreements, and the remaining states have until Sept. 30 to follow. Below are answers to the key questions about the GENEROUS Model.
Related to this article
Rebate delays could force 340B hospitals to pay upfront and wait months for credit, distorting drug spend on the books. Valerie Bandy, PharmD, of Tecsys explains the fallout.
As HRSA's 340B Rebate Model Pilot moves toward its effective date, Valerie Bandy, PharmD, of Tecsys explains what drug-by-drug rebate tracking really demands from hospital and health system pharmacies.
Pharma pricing shifts beyond PBM rebates as Medicare and cash channels reshape launches, WAC cuts and access strategies.
In this week's Pharma Pulse, nine more drugmakers join the MFN program, GoodRx adds a family plan, IPC formalizes its USave partnership, and CSafe expands its thermal cover offerings.
Pharmacy directors are using the growing number of publicly visible drug prices as leverage, new research shows. Manufacturers need to be ready, before those prices become a negotiation tool.
As loss-of-exclusivity events accelerate, generics and biosimilars are diverging into distinct business models, demanding different regulatory, IP, and market access strategies from manufacturers.
Nine more manufacturers join the MFN program, pairing new Medicaid pricing deals with $19.6B in U.S. manufacturing investment and API reserve donations.
Advertisement
Advertisement